Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Eva Fernandez-Diaz"'
Autor:
Eva Fernandez‐Diaz, Jose A. Perez‐Vicente, Ramon Villaverde‐Gonzalez, Leticia Berenguer‐Ruiz, Antonio Candeliere Merlicco, Maria Luisa Martinez‐Navarro, Julia Gracia Gil, Carlos M. Romero‐Sanchez, Arantxa Alfaro‐Saez, Inmaculada Diaz, Juana Gimenez‐Martinez, Maria Angeles Mendez‐Miralles, Jorge Millan‐Pascual, Javier Jimenez‐Pancho, Santiago Mola, Angel P. Sempere
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 8, Iss 2, Pp 385-394 (2021)
Abstract Objective Pivotal trial have shown that patients with multiple sclerosis (MS) receiving ocrelizumab had better outcomes. However, data on ocrelizumab in clinical practice are limited. The aim of this study was to evaluate the preliminary saf
Externí odkaz:
https://doaj.org/article/36e53a30c73a4e0f8bca14d2d0533bc6
Autor:
Tomás Segura, Jorge Garcia-García, Oscar Ayo-Martin, Francisco Hernández-Fernández, Gemma Serrano-Heras, Eva Fernandez-Diaz, María Monteagudo Gómez
Publikováno v:
Future Neurology. 10:529-536
Aim: To evaluate the efficacy, safety and tolerability of rivaroxaban for the secondary prevention of stroke in patients with atrial fibrillation in clinical practice. Methods: Patients treated with rivaroxaban for secondary prevention of stroke/tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f915b930ec8fdfd2e94d4ee7b85f5a60
https://doi.org/10.2217/fnl.15.43
https://doi.org/10.2217/fnl.15.43